Afamelanotide in fair-skinned Parkinson’s patients
17 juin 2024 20h39 HE
|
Clinuvel Pharmaceuticals Limited
CLINUVEL has launch a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease in fair-skinned patients.
Clinical Trials Market Forecast: USD 174.3 Billion by 2033, Driven by 6.8% CAGR | Dimension Market Research
17 juin 2024 12h19 HE
|
Dimension Market Research
New York, June 17, 2024 (GLOBE NEWSWIRE) -- Overview The Global Clinical Trials Market size is expected to reach a market value of USD 96.8 billion and it is further anticipated to reach a market...
US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, Projecting Rapid Adoption Post-Launch
12 juin 2024 12h18 HE
|
Spherix Global Insights
EXTON, PA, June 12, 2024 (GLOBE NEWSWIRE) -- Despite being the second IL-23 inhibitor to enter the market, AbbVie’s Skyrizi (risankizumab) is expected to have a substantial impact on ulcerative...
Insulin Delivery Devices Market Is Expected To Reach a Revenue Of USD 75.4 Bn By 2033, At 8.8% CAGR | Dimension Market Research
11 juin 2024 11h46 HE
|
Dimension Market Research
New York, June 11, 2024 (GLOBE NEWSWIRE) -- The Global Insulin Delivery Devices Market size is expected to reach USD 35.2 billion by 2024 and is further anticipated to reach USD 75.4 billion by 2033...
Biopharma Plastics Market Set for Strong Growth Trajectory, Targeting USD 18,130.3 Million by 2033 | Dimension Market Research
11 juin 2024 11h08 HE
|
Dimension Market Research
New York, June 11, 2024 (GLOBE NEWSWIRE) -- Overview: The Global Biopharma Plastics Market reached USD 5,695.3 million in 2023 and is further anticipated to reach USD 18,130.3 million by 2033...
Biopharmaceutical Market to Reach USD 1,829.2 Billion by 2033, Growing at 15.4% CAGR | Dimension Market Research
10 juin 2024 10h12 HE
|
Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Overview: The Global Biopharmaceutical Market size reached USD 436.7 billion in 2023 and is further anticipated to reach USD 1,829.2 billion by 2033...
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
10 juin 2024 04h00 HE
|
Spherix Global Insights
EXTON, PA, June 10, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
05 juin 2024 09h00 HE
|
Osteal Therapeutics
Osteal Therapeutics secured $50M in Series D financing led by Zimmer Biomet. The funds will advance VT-X7, a treatment for periprosthetic joint infection.
Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial
05 juin 2024 08h00 HE
|
PRISM MarketView
Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
31 mai 2024 08h00 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus